944 results on '"Gozzetti, Alessandro"'
Search Results
2. Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany
3. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia
4. A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
5. Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY
6. Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
7. Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
8. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis
9. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
10. Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
11. p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation
12. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
13. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
14. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis.
15. Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma
16. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia
17. Plasma Cell Leukemia — Facts and Controversies: More Questions than Answers?
18. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
19. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
20. Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs
21. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study
22. Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency
23. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
24. P604: CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE SENSITIVE TO THE APOLIPOPROTEIN E-MEDIATED DISRUPTION OF METABOLIC HOMEOSTASIS
25. S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.
26. Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials
27. Hairy cell leukemia variant and WHO classification correspondence Re: 5thedition WHO classification haematolymphoid tumors: lymphoid neoplasms
28. International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
29. Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia
30. Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
31. Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
32. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
33. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
34. Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma
35. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
36. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
37. SARS‐CoV‐2 infection and vaccination in patients with hairy‐cell leukaemia
38. 796 LEFT ATRIAL STRAIN ASSOCIATION WITH FUNCTIONAL CAPACITY IN CARDIAC AMYLOIDOSIS
39. “Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
40. Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study
41. Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study
42. Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI
43. Long‐term benefit of IGHV mutated patients in a real‐life multicenter cohort of FCR‐treated chronic lymphocytic leukemia
44. Development of a distributed international patient data registry for hairy cell leukemia
45. Steps towards a Multiple Myeloma Cure?
46. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study
47. P-149: Prevalence of type 1 Gaucher disease in patients with multiple myeloma: interim analysis of a prospective, multicentre, observational study
48. Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study
49. Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
50. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.